Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masako HORII
Hemodynamic Effects of Tilisolol, a New .BETA.-adrenergic Blocking Agent With Vasodilating Property, and Doxazosin, a New .ALPHA.-adrenergic Blocking Agent, in Essential Hypertension.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Related publications
Antihypertensive and Hemodynamic Properties of the New Beta Adrenergic Blocking Agent Timolol
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Comparison of Hemodynamic Effects Between .BETA.-blocking Agents and a New Antianginal Agent, Diltiazem Hydrochloride.
Japanese Circulation Journal
Immediate Haemodynamic Effects of a Beta Adrenergic Blocking Agent-Propranolol-In Mitral Stenosis at Fixed Heart Rates.
Heart
Cardiovascular Medicine
Cardiology
A Comparison of Beta Adrenergic Blocking Drugs in the Treatment of Hypertension
Postgraduate Medical Journal
Medicine
Metabolic Studies on CS-359, a New .BETA.-adrenergic Blocking Agent. I. Isolation and Identification of the Urinary Metabolites of CS-359.
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Effects of Arotinolol Hydrochloride ( .ALPHA..BETA. Blocking Agent ) on Insulin Sensitivity.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Beta-Adrenergic Blocking Drugs and Thyroid Function.
BMJ
Clinical Evaluation of Practolol, a New Cardioselective Beta-Blocking Agent in Angina Pectoris
BMJ
Effects of Topical Nipradilol, a Beta Blocking Agent With Alpha Blocking and Nitroglycerin-Like Activities, on Intraocular Pressure and Aqueous Dynamics in Humans
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
